Diligence memo · auto-generated · as of July 2, 2026

Razor Medical Instruments, Inc.

Razor Medical Instruments, Inc. looks over-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Razor Medical Instruments, Inc. operates in Healthtech, based in WARSAW.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Razor Medical Instruments, Inc. has raised $1.3M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $700K on 2020-08-03.

Most recent recorded round closed around 2022-05-27.

Valuation (modeled)modeled

Provath models Razor Medical Instruments, Inc. at approximately $7.1M (range $345K–$45M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 2.55× the median modeled value of Pre-Seed Healthtech companies in 2022–2024 (174 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 11 months.

Last raise 4.1 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round was 1.2× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 31% of Healthtech peers (2138 compared).

Modeled value ranks above 28% of those peers.

Closest niche peers: Hoy Health Corp, Ennova Health LLC, Telebelly Health, Inc., Health Rosetta Group PBC, B2M Medical, Inc..

Peoplefiled

6 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.